2016 88 1 524-545.wang m. carver j. j. phelan v. v. sanchez l. m. garg n. peng y. nguyen d. d. watrous j. kapono c. a. luzzatto-knaan t. porto c. bouslimani a. melnik a. v. meehan m. j. liu w.-t. crusemann m. boudreau p. d. esquenazi e. sandoval-calderon m. kersten r. d. pace l. a. quinn r. a. duncan k. r. hsu c.- c. floros d. j. gavilan r. g. kleigrewe k. northen t. dutton r. j. parrot d. carlson e. e. aigle b. michelsen c. f. jelsbak l. sohlenkamp c. pevzner p. edlund a. mclean j. piel j. murphyb.

maansson m. keyzers r. a. sims a. c. johnson a. r. sidebottom a. m. sedio b. e. klitgaard a. larson c. b. boya p c. a. torres- mendoza d. gonzalez d. j. silva d. b. marques l. m. demarqued.

2012 26 7 801-804.kohlbacher o. reinert k. gropl c. lange e. pfeifer n. schulz-trieglaff o. sturm m. bioinformatics 2007 23 2 e191- e197.caporaso j. g. kuczynski j. stombaugh j. bittinger k. bushman f. d. costello e. k. fierer n. pena a. g. goodrich j. k. gordon j. i. huttley g. a. kelley s. t. knights d. koenig j. e. ley r. e. lozupone c. a. mcdonald d. muegge b. d. pirrung m. reeder j. sevinsky j. r. turnbaugh p. j. walters w. a. widmann j. yatsunenko t. zaneveld j. knight r. nat.

2016 24 1 41-50.sumner l. w. amberg a. barrett d. beale m. h. beger r. daykin c. a. fan t. w.-m. fiehn o. goodacre r. griffin j. l. hankemeier t. hardy n. harnly j. higashi r. kopka j. lane a. n. lindon j. c. marriott p. nicholls a. w. reily m. d. thaden j. j. viant m. r. metabolomics 2007 3 3 211-221.37 nat.

methods 2016 13 10 799-799 10.1038nmeth.4026zhou k. jiang m. liu y. qu y. shi g. yang x. qin x. wang x. plos one 2014 9 6 e98905.nakao a. otterbein l. e. overhaus m. sarady j. k. tsung a. kimizuka k. nalesnik m. a. kaizu t. uchiyama t. liu f. murase n. bauer a. j. bach f. h. gastroenterology 2004 127 2 595-606.40 qin x. gut 2007 56 11 1641-1642.41 chiang j. y. l. j. lipid res.

when background was present this changed to 5.48 to 34.6 and 403 to 724 nm in targeted and untargeted mode data respectively .to understand how different amounts of background affectsthe mass spectrometry signals we added three standards sulfamethizole amitriptyline and sulfachloropyridazine all at 200 nm to the same fecal sample but with different amounts of material ranging from 0.8 to 6.2 mg. the targeted analysis of three added standards revealed measurements variation of 25.1 20.0 and 20.2 for sulfamethizole amitriptyline and sulfachloropyridazine respectively a whereas un- targeted mode results reveal that the data varied with 29.7 26.0 and 28.1 .

despite limited annotations present in existing public reference data sets untargeted metabolomics enables the discovery of compounds associated with specific microbes even in complex samples such as stool areas such as dissolved organic matter sewage or wastewater that have very high diversity of molecules would also benefit from the approaches introduced here.- this sets the stage for population based molecule-microbe association studies that will be critical in further understanding the role of the gut in health and disease.associated contents supporting informationthe supporting information is available free of charge on the at doi .supplemental experimental procedures data and code availability platform quality assessment calibration curves msms comparisons of targeted compounds with authentic standards from the mix of benchmarking solution american gut samples molecular networks paired data statistical analysis and correlations flowchart of complete process of same sample-dual metabolomics workflow list of six standards used in benchmark datasets 1 2 and 3 their physical chemical properties and mrm transitions summary table of limit of detections for six standards with and without fecal background addition summary table of the peak area andrelative standard deviations rsd from 20 samples calculated from targeted data for three standards and untargeted data for ten fecal metabolites summary table of statistical values for procrustes analysis of targeted untargeted and microbiome data summary table of taxa for two pseudomonas containing samples list of 41 standards used in benchmark datasets 4 and 5 and their mrm transitions and references summary table of taxa for all american gut samples analyzed author informationcorresponding authorse-mail regarding the opti- mus and mrmconvert software.e-mail regarding the sequencing.e-mail regarding the mass spectrom- etry the project and interpretation.orcidpieter c. dorrestein author contributionsthe manuscript was written through contributions of all authors.

pubs.acs.orgaccoupling targeted and untargeted mass spectrometry for metabolome-microbiome-wide association studies of human fecal samplesalexey v. melnikricardo r. da silvaembriette r. hydealexander a. aksenovfernando vargas amina bouslimaniivan protsyukalan k. jarmuschanupriya tripathitheodore alexandrov rob knightand pieter c. dorresteincollaborative mass spectrometry innovation center skaggs school of pharmacy and pharmaceutical sciences university of california san diego la jolla california 92093 united statesdepartment of pediatrics university of california san diego la jolla california 92093 united statesssdepartment of computer science  engineering university of california san diego la jolla california 92093 united statesstructural and computational biology unit european molecular biology laboratory heidelberg 69117 germanyuc san diego center for microbiome innovation university of california san diego la jolla california 92093 united states ecent studies show that an imbalance of our microbial ecosystems give rise to significant health problems ranging from cancer asthma allergies infections and weight gain to neurological disorders such as parkinson's disease autism and depression.-in addition to that gut microbiome might be as important to drug metabolism as the liver.much of these microbiome-associated ailments were discovered by under- standing the fecal microbiome through association studies utilizing microbial marker gene or whole genome sequencing data.although these studies contributed to an importantolomics studies related to the microbiome are performed through targeted analysis of known microbiome-associated molecules such as short chain fatty acids secondary bile acids and serotonin and in model systems such as mice.with murine models one can control diet and environment the keyfactors that influence the complexity of the fecal metabolome.

acknowledge funding from the european union's horizon 2020 program under the grant agreement 634402.referenceshsiao e. y. mcbride s. w. hsien s. sharon g. hyde e. r. mccue t. codelli j. a. chow j. reisman s. e. petrosino j. f. patterson p. h. mazmanian s. k. cell 2013 155 7 1451-1463.trompette a. gollwitzer e. s. yadava k. sichelstiel a. k. sprenger n. ngom-bru c. blanchard c. junt t. nicod l. p. harris n. l. marsland b. j. nat.

20168 1 51.yatsunenko t. rey f. e. manary m. j. trehan i. dominguez-bello m. g. contreras m. magris m. hidalgo g. baldassano r. n. anokhin a. p. heath a. c. warner b. reeder j. kuczynski j. caporaso j. g. lozupone c. a. lauber c. clementej.

2016 14 8 508-522.gilbert j. a. quinn r. a. debelius j. xu z. z. morton j. garg n. jansson j. k. dorrestein p. c. knight r. nature 2016 535 7610 94-103.jansson j. willing b. lucio m. fekete a. dicksved j. halfvarson j. tysk c. schmitt-kopplin p. plos one 2009 4 7 e6386.raman m. ahmed i. gillevet p. m. probert c. s. ratcliffen.

methods 2010 7 5 335-336.vazquez-baeza y. pirrung m. gonzalez a. knight r.gigascience 2013 2 1 16.mchardy i. h. goudarzi m. tong m. ruegger p. m. schwager e. weger j. r. graeber t. g. sonnenburg j. l. horvath s. huttenhower c. mcgovern d. p. fornace a. j. jr borneman j. braun j. microbiome 2013 1 1 17.shannon p. markiel a. ozier o. baliga n. s. wang j. t. ramage d. amin n. schwikowski b. ideker t. genome res.

microbiol.2011 60 2 236-245.moran m. a. kujawinski e. b. stubbins a. fatland r. aluwihare l. i. buchan a. crump b. c. dorrestein p. c. dyhrman s. t. hess n. j. howe b. longnecker k. medeiros p.m. niggemann j. obernosterer i. repeta d. j. waldbauer j. r.proc.

furthermore on average only 2 of all metabolomics data in untargeted liquid chromatography-based mass spectrometry experiments can typically be annotated.although one can perform independent targeted and untargeted experiments it is difficult to integrate the data and there is always a level of uncertainty regarding whether the sample that went into the targeted workflow was indeed identical to the sample that went into the untargeted workflow or if an ion observed in one mode corresponds to the same ion in the another.

while providing a quality assurance of the listed data when it is observed the postacquisition strategy is ultimately limited by the limit of detection and dynamic range achievable in a full ms1 scan on an instrument operating in an untargeted acquisition mode compared to a targeted strategy performed on a triple quadrupole which does not enable the discovery of unexpected molecules.-to addressthese challenges we describe a workflow designed for same-sample untargeted and targeted metabolomics with two designated standalone ms instruments.

